Subscribe

    Linda Stein Gold, MD: Updates in Systemic Therapies for Psoriasis

    Psoriasis Advisor
    Dr. Stein Gold discusses insights from clinical trials on new and upcoming systemic agents for psoriasis, including deucravacitinib and bimekizumab.

    More episodes:

    George Martin, MD: The Utilization of TNF Inhibitors for Psoriasis

    Nicole Keeter, MSHS, PA-C: Focusing on Safety Consideration for the Prescription of JAK Inhibitors

    James Del Rosso, DO: Diagnostic Pearls for Psoriasis

    James Del Rosso, DO: Consulting Patients with Psoriasis on Biologic Therapy

    Joel Gelfand, MD, MSCE, FAAD: Managing Cardiovascular Risk in Patients with Psoriasis

    James Del Rosso, DO: Identifying Appropriate Patients for TNF inhibitors

    George Martin, MD: The Current Role of TNF Inhibitors for Psoriasis

    Nicole Keeter, MSHS, PA-C: Incorporating Topical and Oral Treatments into Your Practice

    JCAD

    Journal of Clinical and Aesthetic Dermatology

    Facebook-f X-twitter Instagram Linkedin

    ©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.